Aging and antioxidants modulate rat brain levels of homocysteine and dehydroepiandrosterone sulphate (DHEA-S): Implications in the pathogenesis of Alzheimer's disease

Neuroscience Letters

Volumn 483, Issue 2, 2010, Pages 123-126

  Sinha, Maitrayee ^a   Saha, Ayindrila ^a   Basu, Sumitran ^a   Pal, Keya ^a   Chakrabarti, Sasanka ^a  

^a INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Aging; Alzheimer's disease; Antioxidant supplementation; DHEA S; Homocysteine; Oxidative stress

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; GLUTATHIONE; HOMOCYSTEINE; PRASTERONE SULFATE; THIOCTIC ACID;

AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME ACTIVITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

AGING; ALZHEIMER DISEASE; ANIMALS; ANTIOXIDANTS; BRAIN; DEHYDROEPIANDROSTERONE SULFATE; DISEASE MODELS, ANIMAL; HOMOCYSTEINE; RATS; RATS, WISTAR;

EID: 77956184321     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.07.075     Document Type: Article

References (32)

1. Bagh M.B., Maiti A.K., Roy A., Chakrabarti S. Dietary supplementation with N-acetylcysteine, α-tocopherol and α-lipoic acid prevents age related decline in Na+, K+-ATPase activity and associated peroxidative damage in rat brain synaptosomes. Biogerontology 2008, 9:421-428.
2. Baulieu E.E., Robel P. Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) as neuroactive neurosteroids. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:4089-4091.
3. Celano L., Gil M., Carballal S., Durán R., Denicola A., Banerjee R., Alvarez B. Inactivation of cystathionine beta-synthase with peroxynitrite. Arch. Biochem. Biophys. 2009, 491:96-105.
4. Cuskelly G.J., Stacpoole P.W., Williamson J., Baumgartner T.G., Gregory J.F. Deficiencies of folate and vitamin B6 exert distinct effects on homocysteine, serine, and methionine kinetics. Am. J. Physiol. Endocrinol. Metab. 2001, 281:E1182-E1190.
5. Diamond D.M. Enhancement of cognitive and electrophysiological measures of hippocampal functioning in rats by a low, but not high, dose of dehydroepiandrosterone sulfate (DHEAS). Nonlinearity Biol. Toxicol. Med. 2004, 2:371-377.
6. Diwakar L., Ravindranath V. Inhibition of cystathionine-γ-lyase leads to loss of glutathione and aggravation of mitochondrial dysfunction mediated by excitatory amino acid in the CNS. Neurochem. Int. 2007, 50:418-426.
7. Dringen R., Hamprecht B. N-Acetylcysteine, but not methionine or 2-oxothiazolidine-4-carboxylate, serves as cysteine donor for the synthesis of glutathione in cultured neurons derived from embryonal rat brain. Neurosci. Lett. 1999, 259:79-82.
8. Eloranta T.O. Tissue distribution of S-adenosylmethionine and S-adenosylhomocysteine in the rat Effect of age, sex and methionine administration on the metabolism of S-adenosylmethionine, S-adenosylhomocysteine and polyamines. Biochem. J. 1977, 166:521-529.
9. Geier D.A., Geier M.R. A clinical and laboratory evaluation of methionine cycle-transsulfuration and androgen pathway markers in children with autistic disorders. Horm. Res. 2006, 66:182-188.
10. Genedani S., Rasio G., Cortelli P., Antonelli F., Guidolin D., Galantucci M., Fuxe K., Agnati L.F. Studies on homocysteine and dehydroepiandrosterone sulphate plasma levels in Alzheimer's disease patients and in Parkinson's disease patients. Neurotox. Res. 2004, 6:327-332.
11. Halliwell B., Gutteridge J.M.C. Free Radicals in Biology and Medicine 1999, Oxford University Press, New York. third ed.
12. Hillen T., Lun A., Reischies F.M., Borchelt M., Steinhagen-Thiessen E., Schaub R.T. DHEA-S plasma levels and incidence of Alzheimer's disease. Biol. Psychiatry 2000, 47:161-163.
13. Hoffer E., Baum Y., Tabak A., Taitelman U. N-acetylcysteine increases the glutathione content and protects rat alveolar type II cells against paraquat-induced cytotoxicity. Toxicol. Lett. 1996, 84:7-12.
14. Huang R.F., Huang S.M., Lin B.S., Wei J.S., Liu T.Z. Homocysteine thiolactone induces apoptotic DNA damage mediated by increased intracellular hydrogen peroxide and caspase 3 activation in HL-60 cells. Life Sci. 2001, 68:2799-2811.
15. Isobe C., Murata T., Sato C., Terayama Y. Increase of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer's disease and Parkinson's disease. Life Sci. 2005, 77:1836-1843.
16. Jara-Prado A., Ortega-Vazquez A., Ruano L.M., Rios C., Santamaria A. Homocysteine-induced brain lipid peroxidation: effects of NMDA receptor blockade, antioxidant treatment, and nitric oxide synthase inhibition. Neurotox. Res. 2003, 5:237-243.
17. Kikugawa K., Kato T., Beppu M., Hayasaka A. Fluorescent and cross linked proteins formed by free radical and aldehyde species generated during lipid oxidation. Adv. Exp. Med. Biol. 1989, 266:345-356.
18. Kim S.-B., Hill M., Kwak Y.-T., Hampl R., Jo D.-H., Morfin R. Neurosteroids: cerebrospinal fluid levels for Alzheimer's disease and vascular dementia diagnostics. J. Clin. Endocrinol. Metab. 2003, 88:5199-5206.
19. Koblin T.M., Donald D., Barbara W., Tomerson M.S. Dimethylthiourea, a hydroxyl radical scavenger, impedes the inactivation of methionine synthase by nitrous oxide in mice. Br. J. Anaesth. 1990, 64:214-223.
20. Lindsay J., Laurin D., Verreault R., Hébert R., Halliwell B., Hill G.B., McDowell I. Risk factors for Alzheimer's disease: a prospective analysis from the Canadian study of health and aging. Am. J. Epidemiol. 2002, 156:445-453.
21. Lin T.M., Beal M.F. Mitochondrial dysfunction and oxidative stress in neurodegenerative disease. Nature 2006, 443:787-795.
22. Maayan R., Morad O., Dorfman P., Overstreet D.H., Weizman A., Yadid G. The involvement of dehydroepiandrosterone (DHEA) and its sulfate ester (DHEAS) in blocking the therapeutic effect of electroconvulsive shocks in an animal model of depression. Eur. Neuropsychopharmacol. 2005, 15:253-262.
23. Matsugo S., Yan L.J., Han D., Trischler H.J., Packer L. Elucidation of antioxidant activity of alpha-lipoic acid toward hydroxyl radical. Biochem. Biophys. Res. Commun. 1995, 208:161-167.
24. Moron M.S., Depierre J.W., Mannervik B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim. Biophys. Acta 1979, 582:67-78.
25. Naylor J.C., Hulette C.M., Steffens D.C., Shampine L.J., Ervin J.F., Payne V.M., Massing M.W., Kilts J.D., Strauss J.L., Calhoun P.S., Calnaido R.P., Blazer D.G., Lieberman J.A., Madison R.D., Marx C.E. Cerebrospinal fluid dehydroepiandrosterone levels are correlated with brain dehydroepiandrosterone levels, elevated in Alzheimer's disease, and related to neuropathological disease stage. J. Clin. Endocrinol. Metab. 2008, 93:3173-3178.
26. Nunomura A., Castellani R.J., Zhu X., Moreira P.I., Perry G., Smith M.A. Involvement of oxidative stress in Alzheimer disease. J. Neuropathol. Exp. Neurol. 2006, 65:631-641.
27. Prudova A., Albin M., Bauman Z., Lin A., Vitvitsky V., Banerjee R. Testosterone regulation of homocysteine metabolism modulates redox status in human prostate cancer cells. Antioxid. Redox Signal. 2007, 9:1875-1881.
28. Ryan R.A., Carrol J. Studies on a 3-beta-hydroxysteroid sulphotransferase from rat liver. Biochim. Biophys. Acta 1976, 429:391-401.
29. Seshadri S., Beiser A., Selhub J., Jacques P.F., Rosenberg I.H., D'Agostino R.B., Wilson P.W.F., Wolf P.A. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Engl. J. Med. 2002, 346:476-483.
30. Smith C.U.M. Elements of Molecular Neurobiology 2003, John Wiley and Sons Ltd, West Sussex, England. third ed.
31. Tjiattas L., Ortiz D.O., Dhivant S., Mitton K., Rogers E., Shea T.B. Folate deficiency and homocysteine induce toxicity in cultured dorsal root ganglion neurons via cytosolic calcium accumulation. Aging Cell 2004, 3:71-76.
32. Wolf O.T., Kirschbaum C. Actions of dehydroepiandrosterone and its sulfate in the central nervous system: effects on cognition and emotion in animals and humans. Brain Res. Rev. 1999, 30:264-288.